Figure 3From: Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasisDovitinib inhibited the proliferation of endothelial cells at pharmacologically relevant concentration. A) Dovitinib inhibited the proliferation of endothelial cells under VEGF, PDGF-BB dependent or normal conditions by MTS assay; results were normalized to DMSO controls. B) Proliferation of MHCC-97H and SMMC7721 HCC cells was inhibited only at high concentrations of dovitinib.Back to article page